SILVERMAN LOU has filed 8 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 35000 shares of Insight Molecular Diagnostics Inc. ($IMDX) on July 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 1, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | SILVERMAN LOU | Director | A | Common Stock, no par value | 35000 | $0.00 | 36,564.0000 | 13,071,000 | 2237.85% | 0.27% |
| June 18, 2025 | STAAR SURGICAL CO | $STAA | SILVERMAN LOU | Not found | A | Restricted Stock Units | 10683 | $0.00 | 10,683.0000 | 49,125,000 | 9999.99% | 0.02% |
| June 2, 2025 | Veradigm Inc. | $MDRX | SILVERMAN LOU | Not found | A | Common Stock | 46512 | $4.30 | 56,624.0000 | 112,079,000 | 459.97% | 0.04% |
| May 12, 2025 | STAAR SURGICAL CO | $STAA | SILVERMAN LOU | Not found | A | Common Stock Options | 2440 | $0.00 | 2,440.0000 | 49,125,000 | 9999.99% | 0.00% |
| March 24, 2025 | Veradigm Inc. | $MDRX | SILVERMAN LOU | Not found | A | Common Stock | 10112 | $0.00 | 10,112.0000 | 112,079,000 | 9999.99% | 0.01% |
| July 1, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | SILVERMAN LOU | Director | A | Option to Purchase Common Stock | 30000 | $0.00 | 30,000.0000 | 7,651,000 | 9999.99% | 0.39% |
| June 23, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | SILVERMAN LOU | Director | A | Option to Purchase Common Stock | 112500 | $0.00 | 112,500.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | SILVERMAN LOU | Director | A | Common Stock, no par value | 25000 | $0.00 | 31,270.0000 | 0 | 398.72% | 0.00% |